LINDSAY HOUSE: Open Payments
NPI 1053624809 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 94 payments from 13 companies in 2025. Trend: 2023 $1,512 · 2024 $1,523 · 2025 $1,844
Food & beverage: $1,761Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $518 |
| Regeneron Healthcare Solutions, Inc. | 10 | $244 |
| Janssen Biotech, Inc. | 11 | $213 |
| Lilly USA, LLC | 12 | $200 |
| Novartis Pharmaceuticals Corporation | 11 | $197 |
| UCB, Inc. | 8 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $134 |
| GENZYME CORPORATION | 4 | $73 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Almirall LLC | 1 | $26 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, TALTZ, COSENTYX, Bimzelx, RINVOQ, ILUMYA.
Industry payments across KY — which companies pay providers there.
